Topmoringa – Deltaspharma India

Registered App ID 4151450 Class 5 Word

Trademark information

IP India · live record
Application ID
4151450
Status
Registered
Sub status
Not Applicable
Date of application
18 April 2019
Classes
5
Type
Word
Proprietor
Deltaspharma India Private 2 Nd Floor, Office No. 1 To 5, Shreeji Arcade, Opp. Nitin Company, Dr. Almeda Road, Panch Pakhadi, Thane (W) 400 602
Agent
Hiral C. Joshi.[833]501, Vishwananak, Chakala Road, Andheri (East), Mumbai 400 099.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
18 April 2029

Goods & services

Class 5

Class 5PHARMACEUTICALS, MEDICAL AND VETERINARY PREPARATIONS; SANITARY PREPARATIONS FOR MEDICAL PURPOSES; DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL OR VETERINARY USE, FOOD FOR BABIES; DIETARY SUPPLEMENTS FOR HUMANS AND ANIMALS; PLASTERS, MATERIALS FOR DRESSINGS; MATERIAL FOR STOPPING TEETH, DENTAL WAX; DISINFECTANTS; PREPARATIONS FOR DESTROYING VERMIN; FUNGICIDES, HERBICIDES

PR details

DELTASPHARMA INDIA PVT. LTD., 2ND FLOOR, OFFICE NO. 1 TO 5, SHREEJI ARCADE, OPP. NITIN COMPANY, DR. ALMEDA ROAD, PANCH PAKHADI, THANE (W) - 400 602, BODY INCORPORATED INCLUDING PRIVATE LIMITED COMPANY, (Body Incorporate)

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 18 Apr 2019
2 Reply to Exam Report (MIS-R) 15 Jun 2019
3 Authorization Letter 03 Dec 2019
4 Journal Copy 03 Aug 2021
5 Certificate 03 Dec 2021

Correspondence and notices

1 EXAMINATION REPORT 8342947 30 May 2019
2 Hearing Notice (Show Cause) 9150927 · 4556799 24 Oct 2019
3 Hearing notice (Adjourned) 9726841 · 4807456 07 Feb 2020
4 Hearing Notice (Show Cause) 11400975 19 Apr 2021
5 Hearing Notice (Show Cause) 11518842 18 May 2021
6 Tribunal Accepted Notice for : 4151450 11767094 · 5235897 05 Jul 2021

Frequently asked questions

Topmoringa was applied for on 18 April 2019.

The application was filed by Deltaspharma India.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Topmoringa is 4151450.

Trademark attorney Hiral C. Joshi.